Truvada Protected 100 Percent Of Study Participants From HIV
A study of 657 people taking PrEP, the daily pill that can prevent HIV, has found that not a single person contracted the potentially deadly virus over two and a half years of observation.
The research showed that despite rising rates of STIs in the group, as well as a decline in condom use, the pill was able to protect everyone involved from HIV. The study was conducted by doctors from Kaiser Permanente, a managed care company based in Oakland, California.
More...